Podcasts about Reimbursement

Taylor Swift Today, one week later, with Lyla: the newlyweds have vanished into married life, the wild details are still trickling out, and we finally know how we'll see the dress. A Dior spokesperson confirmed that Taylor Swift herself will share the first official wedding photos on her own Instagram — no date yet, exactly the way she's controlled this story from day one. Plus the first sighting of Taylor since the wedding (a low-key Montana getaway with her new in-laws), the city reimbursement that settled the "who paid" debate, and a few late details that'll make you smile. Here's the week-later check-in.

TODAY ON THE ROBERT SCOTT BELL SHOW: Reimbursement Code Monopoly, Prof. Dr. Dana Flavin, Foundation for Collaborative Medicine and Research, Hydrangea Arborescens, Politicized Science, Dr. Stephanie Haridopolos, HHS Agenda, Health Freedom, Americans Quitting Multivitamins and MORE! https://robertscottbell.com/reimbursement-code-monopoly-prof-dr-dana-flavin-hydrangea-arborescens-politicized-science-dr-stephanie-haridopolos-americans-quitting-multivitamins/ Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Michael Penn, US Head of Reimbursement and Public Policy at Sanofi, to discuss how pricing policy, the Inflation Reduction Act (IRA), small-molecule incentives, orphan drug provisions, and Most Favored Nation (MFN) proposals could shape oncology innovation, patient access, and U.S. biopharmaceutical competitiveness. Key Topics: IRA and Oncology: Late-stage research shifts, follow-on studies, lead asset selection. Small-Molecule Incentives: Pill penalty concerns, portfolio reassessment, biologic comparisons. Orphan Drug Policy: Orphan Cures Act provisions, rare disease investment, post-market indication development. Patient Access Risks: Fewer treatment options, affordability questions, unmet needs in oncology. U.S. Competitiveness: MFN proposals, global R&D incentives, comparisons with China and Europe. Our new preprint on the IRA’s impact on late-stage R&D is available on our website and examines declines in small-molecule oncology research and orphan oncology studies. Opinions expressed are those of the speakers. Recorded at ASCO 2026 on 5/31/26. The Vital Health Podcast is a production of Vital Transformation LLC © 2026.See omnystudio.com/listener for privacy information.

Joe Rodriguez (co-founder, Guide Anesthesia) sits down with Randy Moore (EVP and National Chief CRNA, NorthStar Anesthesia) and Gary Keeling (VP of Anesthesia Services, Coronis RCM). Three seats, three vantage points on the same business. Let the spicy takes flow. First docket: the Arizona reimbursement fight. Gary calls the QZ cut a pure money grab. Randy steelmans the insurer's lobbyist before dismantling him, and explains why the hospitals least prepared to absorb the hit will be the ones paying it. Joe walks through why reimbursement parity doesn't raise costs when subsidies fill the gap, and tells the story of the insurer that paid patients directly for eight years. Second docket: the Texas non-compete case. Gary argues exits should hurt but not kill. Randy says hospitals deserve the right to fire bad vendors, but a $30 million buyout is anti-competitive. Joe draws the line between covenants that trap clinicians and the non-solicit rule that just says don't be shady. Plus: why the resume from Hawaii is a red flag, and what the law of inertia does to anesthesia groups that confuse stability with health. Takeaways: The QZ cut is not a savings. It's a transfer. Hospitals backstop anesthesia economics, so a 15% commercial reimbursement cut flows through subsidies to hospitals and ultimately taxpayers, while insurers book the difference. Reimbursement parity does not raise costs in anesthesia. Compensation sits above reimbursement and subsidies fill the gap, so cutting one payer's rate changes who pays, not how much is paid. The facilities that use QZ most are the ones least able to absorb the cut. Rural and underserved programs run closest to the margin, which makes this bad policy independent of the scope debate. CRNAs can lose non-compete fights. In the Texas case, the new employer contractually agreed to cover legal costs and damages, and the court sided with the original group anyway. A buyout promise is not a shield. The covenant you signed is enforceable as written, and "I read online it's unenforceable" is not a legal strategy. The line is solicitation, not competition. A non-solicit protects the group that gave you access to its surgeons and referrals without trapping you in place. Competing down the street is fair game. Taking the business with you is shady. Switching costs are a strategy. A $30 million buyout stops being protection and becomes a hostage situation. Hospitals should be able to fire bad vendors at a price that hurts but doesn't kill. Sign contracts like you plan airways. Have a plan A, B, and C for your exit before the honeymoon period ends, because the group that looks great at signing may not look great in year three. Want more Dr. Joe Rodriguez? Tik Tok: @jrodcrna21 Instagram: @jrod.crna & @abouttherestpod YouTube: @AboutTheRest Thanks for my co-hosts: Randy Moore (EVP & National Chief CRNA, NorthStar Anesthesia) Gary Keeling (VP of Anesthesia Services, Coronis RCM) To Learn More about Human Content Visit: ⁠⁠⁠http://www.human-content.com⁠⁠⁠ To Learn More about About The Rest Visit: www.abouttherest.com Got a Question? hello@abouttherest.com Part of the Human Content Podcast Network Learn more about your ad choices. Visit megaphone.fm/adchoices

A new CEO steps into The Rose and immediately confronts the realities behind 60,000annual screenings: rural healthcare deserts, under‑reimbursed mammograms, and anaging but essential mobile fleet. During this conversation, COO Jessica Duckworth sits down with Angie Lane to talk aboutwhat surprised her most in her first six weeks, why 3D mammography on five pinkcoaches is non‑negotiable for twenty‑six Texas counties with no freestanding imaging,and how shrinking insurance and Medicare payments make patient navigation andfinancial stewardship core to The Rose’s future. Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1. What did Angie learn in her first weeks about serving 60,000 women a year acrossforty‑five counties?2. How do The Rose’s five mobile coaches deliver 3D mammograms in counties with noimaging centers at all?3. Why does Angie describe many of The Rose’s service areas as “healthcare deserts”?4. What does it actually cost The Rose to provide a screening compared to what manyinsurers and Medicare reimburse?5. How does Angie connect her new role to her experience as a working mother who mighthave to lose a day’s work just to reach the medical center?6. Why does she see patient navigation as a uniquely important service for women whoreceive a cancer diagnosis?7. How does Angie’s personal experience hearing a difficult diagnosis about her childshape her empathy for patients at The Rose?8. What financial priorities does Angie name for keeping The Rose stable whilemaintaining high standards of care?9. How does Jessica frame the dual challenge of limited healthcare options and limitedhealth insurance in rural Texas? Timestamped Overview00:00 Jessica welcomes listeners, introduces herself as COO of The Rose, and framesthe episode as a chance for the community to meet new CEO Angie Lane.00:25 Angie thanks Jessica and shares her awe at the scale of The Rose’s work,including serving 60,000 women annually and operating the largest mobilemammography fleet in Texas.00:30 She describes the five RV coaches, their 24‑hour air‑conditioning, bumpy ruralroads, and sophisticated equipment required to bring mammograms to areas withoutfreestanding clinics.01:13 Jessica notes that out of The Rose’s forty‑five‑county service area, twenty‑sixcounties have no freestanding mammography units, making the mobile fleet essential.01:19 She adds that the coaches carry 3D mammography, the gold standard, whichmany local facilities still do not offer.01:33 Angie reflects on growing up near the Texas Medical Center, contrasts thataccess with surrounding counties she now sees as healthcare deserts, and imaginesthe burden on working mothers who would have to take a full day to reach the medicalcenter for routine screening.02:21 Jessica points out that rural communities face deserts in both healthcare servicesand health insurance coverage, compounding access gaps.02:50 Angie explains that providing a mammogram can cost The Rose around $300,while some reimbursements come in around $150–$175, and says closing that gapwithout sacrificing quality is a priority.03:36 Jessica highlights The Rose’s patient navigation program and asks Angie howshe views its importance and future.04:11 Angie calls navigation one of The Rose’s most important services, connects it toher own experience hearing a diagnosis about her child, and underscores howoverwhelming cancer can be even for people already working in healthcare.06:00 Angie talks about the emotional load on patients and families and why having askilled, compassionate navigator alongside them can change the experience oftreatment.07:15 Jessica and Angie touch briefly on funder conversations, the need to explain thatsupport goes far beyond “just a mammogram,” and how navigation, follow‑up, andsystem gaps factor into funding requests.09:30 Angie closes by returning to her core goal: protecting access and quality for everywoman The Rose serves while steering the organization safely through shiftingreimbursement and rural need.See omnystudio.com/listener for privacy information.

In this episode of Medsider Radio, we sat down with Dr. Sudhir Srivastava, founder, chairman, and CEO of SS Innovations (Nasdaq: SSII). The company's SSi Mantra surgical robotic system supports a variety of surgical robotic procedures, including cardiac surgery. Sudhir brings more than three decades of experience in minimally invasive and robotic cardiac interventions, having served as Director of Robotic Cardiac Surgery at the University of Chicago and founder of the International College of Robotic Surgery. A pioneer in the field, Sudhir has performed more than 1,400 robotic procedures, including over 750 beating-heart totally endoscopic coronary artery bypass (TECAB) surgeries.In this interview, Sudhir discusses what it takes to democratize robotic surgery beyond affordability, how SS Innovations built teleproctoring, telesurgery, and the supporting infrastructure for its robotic platform, and his milestone-based approach to financing a capital-intensive medtech company. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Sudhir Srivastava, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:01) - Sudhir's journey from performing the world's first beating-heart robotic bypass to founding SS Innovations (07:14) - The 22-year-old patient who became the catalyst for Sudhir's affordable robotic surgery platform (08:59) - Building Mantra 3 from the ground up in just five months (12:14) - Inside the engineering process that eliminated months of costly iteration (16:20) - The question that shaped SS Innovations: "How do you democratize access?" (27:10) - From one office to performing 24 telesurgeries in 12 hours across India (29:29) - How a mobile training bus became part of Sudhir's answer to make robotic surgery accessible (33:49) - Lessons from commercializing a surgical robotics platform across developing markets (39:43) - Starting with just $5 million: Sudhir's milestone-based approach to fundraising

See omnystudio.com/listener for privacy information.

Healthcare providers are losing valuable time and revenue navigating an outdated insurance system, but what if artificial intelligence could change everything?In this episode of TechTalk Healthcare, Brad Cost and Dr. Jay Greenstein explore how AI could completely transform healthcare reimbursement, insurance claims processing, fraud detection, and provider payments.Together they discuss why insurance companies continue relying on decades-old systems, how AI could approve claims in milliseconds, and why providers deserve faster, fairer reimbursement.They also dive into the role of government regulation, insurance competition, real-time adjudication, and how data transparency can reshape the future of healthcare.Whether you're a chiropractor, healthcare executive, practice owner, revenue cycle professional, or simply interested in AI's impact on healthcare, this episode offers a thought-provoking look at where the industry is headed.You'll learn:How AI can automate insurance claims processingWhy providers wait weeks (or months) to get paidThe future of real-time claim adjudicationHow AI can reduce healthcare fraudWhy healthcare reimbursement needs reformHow data sharing could strengthen provider advocacyThe role of AI in improving patient access to care

In this episode of Medsider Radio, we sat down with Aditya Rajagopal, co-founder and CEO of Esperto Medical.Esperto is a Caltech spin-out utilizing compressed sensing technology with ultrasound to continuously and non-invasively measure blood pressure.Before Esperto, Aditya co-founded ChromaCode, a molecular diagnostics company, and was a researcher at Google[x], where he worked on novel medical imaging methods. Aditya also serves as part-time faculty at Caltech and USC, and holds BS, MS, and PhD degrees in Electrical Engineering from Caltech. In this interview, Aditya discusses why great science doesn't necessarily make great companies, what it takes to win as a fast-follower in medtech, and how to sequence a platform technology without spreading resources too thin.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Aditya Rajagopal, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(02:44) - Aditya's journey from Caltech and Google to tackling one of medicine's hardest engineering problems at Esperto (05:17) - How Esperto is trying to solve a 50-year-old problem: continuous blood pressure monitoring without an arterial catheter (07:17) - Why Esperto was okay with being a fast-follower in an established market instead of creating a new one (16:12) - "Great science doesn't necessarily make great companies" and other lessons Aditya learned at ChromaCode (24:02) - Three hurdles every medical device must clear before clinicians will actually adopt it (27:44) - How Aditya determines whether a technical problem actually has a "there there" (37:51) - Esperto's pitch strategy and how it raised from a position of strength (43:18) - What first-time founders often misunderstand about how venture capital actually works

Another conversation with Dr. Brian Gantwerker Find the video of this conversation at https://youtu.be/Bsyg_f7HoCw

In this episode of Medsider Radio, we sat down with Eric Kau, co-founder and CEO of Climatic.Climatic is commercializing L Max, a daily inhaled system that proactively supports lung function.Before Climatic, Eric served as COO of Seed Health and was part of the foundational team at Chewy. Earlier in his career, Eric held growth and operational leadership roles across consumer, wellness, and e-commerce businesses, including Amazon, BoxyCharm, Target, and Best Buy. In this interview, Eric discusses what it takes to build a consumer category that doesn't yet exist, how Climatic approached clinical validation and consumer education simultaneously, and how early user behavior helped identify the company's strongest initial customer cohorts.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Eric Kau, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(02:49) - Eric's path through Amazon, Chewy, Seed, and the consumer health experiences that led to Climatic (05:49) - Why Climatic is treating lung health like hydration, sleep, or nutrition (11:47) - How Climatic rapidly iterated on formulas, delivery systems, and prototypes to launch a product for a new category in under 2 years (14:56) - Climatic's approach to product design, which is built around gym bags, vanities, and existing wellness routines (19:59) - How early users shaped both Climatic's clinical strategy and its go-to-market focus on endurance athletes and biohackers (23:56) - Why Climatic spent more time teaching consumers about lung health than selling the product itself (34:07) - What investors needed to believe before funding a category that didn't yet exist (40:27) - How Climatic built a 15,000-person waitlist through Strava run clubs instead of paid ads

Ask a burned-out pelvic therapist what's draining them and they'll usually say the same thing: it's a lot. The emotional weight of the work, the intimacy of the specialty, the complexity of the cases.But that's not what's actually breaking providers.Pelvic therapists who love their patients are burning out anyway — because the system they work inside was never designed to sustain them. Documentation that bleeds into evenings. Reimbursement rates that haven't kept pace with inflation in a decade. Visit lengths decided by insurance instead of clinical need. And no business training to help them see the exit before they hit the wall.In this episode, Kelly breaks down the real structural drivers of burnout in pelvic health — the ones that have nothing to do with your caseload and everything to do with the model you inherited. She covers the documentation load nobody warned you about in school, the autonomy gap that comes with insurance dependency, and why this is a practice design problem — not a mindset problem, not a resilience problem, and not a you problem.She also covers what the providers who escaped burnout actually did differently. Not the ones who took a vacation and came back to the same broken model. The ones who restructured and stayed.By the end of this episode, you'll know exactly what broke — and where to start fixing it.KEY TAKEAWAYSPelvic therapist burnout is structural, not personal — it's a model problem built into the system before you ever graduatedDocumentation load, reimbursement erosion, and the autonomy gap are the three real drivers — not patient volume or emotional laborThe providers who escaped burnout didn't work less — they rebuilt the model that was consuming them

ANNOUNCEMENT: If you're a caregiver based in New York State or still have family in New York, join me on Thursday June 18th for my webinar, Caregiving: A Public Health Issue. 8pm est; $15 per person.Sign up here: https://www.eventbrite.com/e/1991026454723?aff=oddtdtcreatorOn this episode of The Social Work Rants Podcast, I discussed the changes to reimbursement rates for providers using CPT codes 90834 and 90837 on the Alma platform, effective July 15th. The changes involve adjusting the rates for session durations, with code 90837 (53 minutes and up) being reimbursed at the same rate as code 90834 (37-52 minute sessions). Basiliso also mentioned the impact of inflation on these changes, citing a recent 4.2% inflation rate.Inflation and Mental Health ConcernsI discuss the impact of inflation on various aspects of life, including healthcare costs and gas prices, noting that while President Biden reduced the national inflation rate, many expenses continue to rise. I expressed concerns about technology platforms like Headway that visually scan patients during mental health sessions, citing ethical issues around patient privacy and surveillance. I also mentioned challenges with audits and payment reimbursements for agencies.I highlight the work of Justin Gillespie from Blue Cross Blue Shield of Michigan, who is working on legislation to address reimbursement rates at both state and national levels.Payer Regulation Impact on NonprofitsI discussed recent payer regulation changes affecting Medicaid and HMO services, including increased denial rates and higher audit frequencies leading to potential nonprofit closures. They highlighted budget issues in New York City affecting nonprofit organizations' ability to pay staff and bills. Basiliso noted that the full impact of the HR1 legislation may not be fully realized until after the November general election.Medicaid Recertification Changes UpdateI also warned about upcoming changes to Medicaid recertifications and a new work requirement effective in July, which will require individuals to show proof of working up to 80 hours to maintain their benefits. These changes will significantly impact vulnerable populations and make social workers' jobs more challenging. The discussion was presented as educational content to help professionals understand the evolving landscape affecting their work.

This week, “Marketplace Morning Report” host Kimberly Adams has been in Thomasville, Alabama as part of our series examining the economic challenges facing rural health care. This morning, we'll look at how low wages in Alabama can mean low Medicare reimbursement rates — shaping how much doctors and nurses get paid, and how much money hospitals and clinics can make. But first, we'll cover how solar power use in the U.S. is hitting new milestones amid energy price fluctuations.

This week, “Marketplace Morning Report” host Kimberly Adams has been in Thomasville, Alabama as part of our series examining the economic challenges facing rural health care. This morning, we'll look at how low wages in Alabama can mean low Medicare reimbursement rates — shaping how much doctors and nurses get paid, and how much money hospitals and clinics can make. But first, we'll cover how solar power use in the U.S. is hitting new milestones amid energy price fluctuations.

In this episode of Medsider Radio, we sat down with Kara Egan, founder and CEO of Teal Health.Teal Health is the company behind the first FDA-authorized at-home cervical cancer screening wand.Before founding Teal, Kara worked in healthcare and software investing at .406 Ventures and Emergence Capital, and held product and marketing roles at Zendesk and Stitch Labs.  In this interview, Kara discusses building support and follow-up into at-home screening, how Teal expanded its comparative clinical study to support broader market adoption, and how healthcare incentives, reimbursement, and institutional trust shape new care models.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Kara Egan, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(02:49) - Kara's background in health technology investing and software that shaped Teal's consumer-first approach (05:14) - How Teal turned the traditional Pap smear into the first FDA-authorized at-home screening product (07:30) - Turning at-home testing, telehealth, and clinician follow-up into a single care experience (13:48) - Raising Teal's first $1M with mockups and consumer-grade design (22:17) - Teal's comparative study that matched physician-collected screening with 96% sensitivity (23:40) - How asking women what they actually wanted changed Teal's view of the market opportunity (32:05) - “Take off the healthcare hat” — Kara's framework for fundraising, incentives, and commercialization (41:48) - What investors actually care about beyond the company's mission

Mayor Gary Moore and City Manager Kasey Mitchell joined Wake Up Tri-Counties to talk about the city-wide cleanup on June 6th, upcoming road construction, the sidewalk reimbursement program, and Hog Days. Kewanee residents are encouraged to take part in city-wide Cleanup Day, which will take place on Saturday, June 6th, from 7 AM until noon. Participants should ensure all items are bagged or boxed for quick unloading, helping keep the area clean and efficient. Proof of an address within Kewanee is required. Volunteers are needed to assist with unloading vehicles and placing materials into large dumpsters. Extra hands are necessary to help the process move smoothly for everyone involved. Anyone interested in volunteering should show up Saturday morning. Join the effort to keep the city looking its best and make a difference in your community. If the event is postponed due to rain, the backup date is next Saturday. Restrictions include no electronics, toner, or liquids such as paint. The city is also promoting involvement in upcoming events, including Hog Days, and highlighting summer construction projects and a sidewalk reimbursement program.

In this episode, Mark Domayhn, Partner at JD Lymon Group, joins Duane Mancini to unpack what medtech innovators often miss most: reimbursement isn't a box to check after FDA—it's the commercial foundation that determines whether hospitals and physicians can adopt your technology. Drawing on experience across Medtronic, Zimmer, and St. Jude/Abbott, Mark breaks down the “three-legged stool” of coverage, coding, and payment, why clinical evidence must satisfy payer standards (not just FDA), and how to “follow the money” across fragmented U.S. systems. The conversation then dives into the New Technology Add-On Payment (NTAP) program, why it matters for inpatient launches, how breakthrough designation has increased NTAP success, and the major implications of CMS proposing to repeal the alternative pathway—plus what companies can do before the June 9 comment deadline. Mark Domyahn LinkedInJD Lymon Group WebsiteRAPID Coverage Pathway InformationDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedInThank you to our sponsors: Ward Law and JumpStart Inc.

In this episode of Medsider Radio, we sat down with Karthik Ganesh, CEO of OnMed.OnMed is the healthcare technology company behind OnMed CareStation, a “Clinic-in-a-Box” designed to expand access to primary and urgent care. Before OnMed, Karthik served as CEO of EmpiRx Health, leading the company through rapid growth and a successful private equity transaction in 2021. Throughout his career, he's held leadership roles at QualCare, CareAllies, and Aetna, and advised healthcare organizations through Deloitte and EY.In this interview, Karthik discusses why hybrid care models still require a human touch, how enterprise healthcare buyers evaluate value propositions differently, why brand and culture should shape execution early, and how operating under constraints can sharpen innovation.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Karthik Ganesh, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:04) - Karthik's obsession with healthcare access, and the “broken doorway” problem behind OnMed (05:51) - How OnMed combines telemedicine and brick-and-mortar care into a “Clinic in a Box” (09:04) - The OnMed metrics that surprised Karthik most, including a 37% patient return rate, and the reasons behind the company's success (09:22) - What OnMed designed differently after realizing that patients approach healthcare with their guard up (15:27) - The pitfalls of B2C healthcare and how OnMed was built as a B2B company by intention (22:01) - How Karthik reshaped OnMed around clarity, structure, and high performers (30:23) - What “brand” actually means to Karthik (39:37) - How OnMed tailored its value proposition for payers, providers, employers, and universities (45:45) - Karthik's fundraising philosophy: constraints keep companies inventive

It's Thursday, May 28. Here are today's top stories around Central Indiana. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org and follow us on social media to get local news every day. WFYI News Now is hosted by Barb Anguiano and produced by Zach Bundy. Subscribe wherever you get your podcasts.

Paris based journalist Elaine Cobb and Prof Donal O'Shea endocrinologist and HSE Clinical lead for Obesity 

Most physical therapists know something's broken. Reimbursements are declining. Administrative burden is rising. And despite delivering massive value, the profession is still treated like an afterthought.In this episode of the Private Practice Owners Podcast, Nathan Shields sits down with Scott Gardner—clinic owner and leader of the United Physical Therapy Association—to unpack the real reason behind the industry's struggles.From the “ancillary provider” label to Medicare policy, Scott breaks down why physical therapists are stuck at the bottom of the healthcare hierarchy—and what it will actually take to change that.This isn't theory. This is a behind-the-scenes look at the legislative, financial, and systemic forces shaping your clinic's future.In this episode, you'll learn:Why physical therapists are still classified as “ancillary” providers—and why it mattersThe real reason reimbursements keep decliningHow Medicare policy directly impacts your clinic revenueWhat MPPPR is (and why it's quietly costing you thousands)The truth about “opting out” of MedicareWhy most therapists complain—but don't take actionHow advocacy and legislation shape the future of private practiceWhat needs to happen for PTs to gain autonomy and higher payWhy unity across clinics may be the only way forwardThis episode is not about quick wins. It's about understanding the system—and how to actually change it.

In this episode of Medsider Radio, we sat down with Dr. Connie Lehman, founder and CEO of Clairity.Clairity is the first FDA-authorized AI platform that predicts a woman's five-year risk of developing breast cancer using only a routine screening mammogram.A physician scientist with over 300 peer-reviewed publications, Connie is a Professor of Radiology at Harvard Medical School and Breast Imaging Specialist at Massachusetts General Brigham (on leave). She holds an MD and PhD from Yale and was named to Forbes' 50 Over 50 Innovators and TIME 100 World's Most Influential Leaders in Health.In this interview, Connie discusses her experience translating academic research into a commercially viable startup, the massive undertaking of generating clinical evidence when you're creating a new category, and how Clairity is approaching adoption on two fronts: fitting into physician workflows and building access pathways for patients.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Connie Lehman, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:04) - The broken screening paradigm Connie saw in clinic — and the gap that became Clairity (05:09) - How Clairity rolls the clock back from detection to predicting risk in healthy women (07:31) - Why "more data is better" turned out to be wrong and how that shaped Clairity's product scope (21:57) - How physicians can translate grant-generating discipline into building a company (24:56) - What 18 months of pre-sub meetings revealed about navigating a de novo pathway (26:49) - Why Clairity validated its technology in over 250,000 mammograms when FDA required far less (34:43) - How Connie flipped the natural question from "how can doctors offer this?" to "how can women access it?" (43:47) - How relationships, not pitches, drove Clairity's $43M Series B

Send us Fan MailHospice has always been about people, but the future of hospice will increasingly be shaped by data—and that shift is both exciting and unsettling.In Part Two of The Future of Hospice: How HOPE Will Transform Reimbursement & Care, Raianne Melton and Andrea Hale unpack how the HOPE tool could redefine hospice reimbursement, value-based care, and quality measurement across CMS, Medicare Advantage, and health systems. The conversation explores where hospice measurement may be heading—from symptom impact scoring and burdensome discharges to acuity tracking, HUV utilization, and the growing importance of consistent documentation and actionable clinical data.The episode also focuses on what hospice leaders can do now to prepare: improving point-of-care documentation, simplifying EMR workflows, leveraging real-time analytics, and exploring AI-powered ambient listening to reduce clinician burden while preserving compassionate care. Ultimately, this conversation is about helping hospice organizations prove their value with measurable outcomes while staying true to the mission that defines hospice care.This episode offers practical insights for hospice executives, nonprofit healthcare leaders, clinicians, and anyone navigating the evolving landscape of end-of-life care.Guest:Andrea Hale, CEO of Valley Hospice Raianne Melton, Director of Clinical Services of Professional Services for AxxessHost:Chris Comeaux, President / CEO of TELEIOS and author of The Anatomy of LeadershipThe Anatomy of Leadership podcast explores the art and science of leadership through candid, insightful conversations with thought leaders, innovators, and change-makers from a variety of industries. Hosted by Chris Comeaux, each episode dives into the mindsets, habits, and strategies that empower leaders to thrive in complex, fast-changing environments. With topics ranging from organizational culture and emotional intelligence to navigating disruption and inspiring teams, the show blends real-world stories with practical takeaways. The goal is simple yet ambitious: to equip leaders at every level with the tools, perspectives, and inspiration they need to lead with vision, empathy, and impact.https://www.teleioscn.org/anatomy-of-leadership

Hospice has always been about people, but the future of hospice will increasingly be shaped by data—and that shift is both exciting and unsettling.In Part Two of The Future of Hospice: How HOPE Will Transform Reimbursement & Care, Raianne Melton and Andrea Hale unpack how the HOPE tool could redefine hospice reimbursement, value-based care, and quality measurement across CMS, Medicare Advantage, and health systems. The conversation explores where hospice measurement may be heading—from symptom impact scoring and burdensome discharges to acuity tracking, HUV utilization, and the growing importance of consistent documentation and actionable clinical data.The episode also focuses on what hospice leaders can do now to prepare: improving point-of-care documentation, simplifying EMR workflows, leveraging real-time analytics, and exploring AI-powered ambient listening to reduce clinician burden while preserving compassionate care. Ultimately, this conversation is about helping hospice organizations prove their value with measurable outcomes while staying true to the mission that defines hospice care.This episode offers practical insights for hospice executives, nonprofit healthcare leaders, clinicians, and anyone navigating the evolving landscape of end-of-life care.Guest:Andrea Hale, CEO of Valley Hospice Raianne Melton, Director of Clinical Services of Professional Services for AxxessHost:Chris Comeaux, President / CEO of TELEIOS and author of The Anatomy of LeadershipTeleios Collaborative Network   /   https://www.teleioscn.org/tcntalkspodcast

Send us Fan MailThe future of hospice care is changing—and the HOPE assessment tool may redefine how providers deliver care, document outcomes, and receive reimbursement.Healthcare is entering a new era where quality outcomes, patient data, and accountability are driving the future of care delivery.  In this episode, we're joined by Andrea Hale, CEO of Valley Hospice, and Raianne Melton, Director of Clinical Services of Professional Services for Axxess, whose expertise and frontline perspective help unpack one of the most significant shifts happening in hospice today—the implementation of the HOPE assessment tool. Their insight provides valuable guidance for hospice leaders, clinicians, and organizations preparing for the future of reimbursement and patient-centered care.In Part One of this important conversation, we explore how the Hospice Outcomes & Patient Evaluation (HOPE) tool is poised to transform the hospice landscape.  From evolving CMS expectations to the growing emphasis on quality metrics and patient-centered outcomes, this episode breaks down what hospice leaders, clinicians, and healthcare organizations need to understand now.Join us as we discuss:• What the HOPE tool is and why it matters• How reimbursement models are shifting in hospice care• The operational and compliance challenges providers may face• Why documentation and quality reporting are becoming more critical than ever• How organizations can proactively prepare for the future of end-of-life careWhether you're a hospice professional, nonprofit executive, healthcare leader, or business decision-maker, this episode provides timely insight into the changing future of compassionate care delivery.Our Guest:Andrea Hale, CEO of Valley HospiceRaianne Melton, Director of Clinical Services of Professional Services for AxxessHost:Chris Comeaux, President / CEO of TELEIOS and author of The Anatomy of Leadership

The future of hospice care is changing—and the HOPE assessment tool may redefine how providers deliver care, document outcomes, and receive reimbursement.Healthcare is entering a new era where quality outcomes, patient data, and accountability are driving the future of care delivery.  In this episode, we're joined by Andrea Hale, CEO of Valley Hospice, and Raianne Melton, Director of Clinical Services of Professional Services for Axxess, whose expertise and frontline perspective help unpack one of the most significant shifts happening in hospice today—the implementation of the HOPE assessment tool. Their insight provides valuable guidance for hospice leaders, clinicians, and organizations preparing for the future of reimbursement and patient-centered care.In Part One of this important conversation, we explore how the Hospice Outcomes & Patient Evaluation (HOPE) tool is poised to transform the hospice landscape.  From evolving CMS expectations to the growing emphasis on quality metrics and patient-centered outcomes, this episode breaks down what hospice leaders, clinicians, and healthcare organizations need to understand now.Join us as we discuss: • What the HOPE tool is and why it matters • How reimbursement models are shifting in hospice care • The operational and compliance challenges providers may face • Why documentation and quality reporting are becoming more critical than ever • How organizations can proactively prepare for the future of end-of-life careWhether you're a hospice professional, nonprofit executive, healthcare leader, or business decision-maker, this episode provides timely insight into the changing future of compassionate care delivery.Our Guest:Andrea Hale, CEO of Valley HospiceRaianne Melton, Director of Clinical Services of Professional Services for AxxessHost:Chris Comeaux, President / CEO of TELEIOS and author of The Anatomy of Leadership

In this episode of Medsider Radio, we sat down with Antony Odell, co-founder and CEO of Echopoint Medical.Echopoint is a London-based UCL spinout developing iKOr, an optical microcatheter for coronary diagnostics.Antony brings over 30 years of medtech experience across Johnson & Johnson, Fresenius, and Stryker, before transitioning into startups as CEO of Tayside Flow Technologies and Tissue Regenix. He holds a BSc in Physiology and Biochemistry.In this interview, Antony discusses translating academic IP into a commercial device, choosing early clinical sites to balance speed and learning, managing non-dilutive funding as a long-term discipline, and outlines the most important responsibilities of an early-stage medtech CEO.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Antony Odell, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:06) - How Antony's career centered on translating clinical insights into commercial reality (05:54) - What Echopoint's iKOr does, and why 40% of cath lab patients leave without a diagnosis (12:13) - How Echopoint landed its first U.S. clinical site, and what that means for the company (13:48) - What to assess before spinning out an academic idea, and why clinician input is the first real test (20:14) - Why Echopoint chose Barts over typical sites for its first-in-human study (22:58) - How getting too close to one clinical site can lead to dangerous groupthink (30:54) - Why non-dilutive funding belongs on the board agenda permanently (39:54) - How CEOs should manage boards, control information flow, and avoid becoming a “glorified note-taker”

May 15, 2026In this special live episode from the AUA Annual Meeting in Washington, D.C., Scott, Mark, and Ray Painter share highlights from the AUA Innovation Nexus program, where emerging companies, investors, and industry leaders are working to bring new urology technologies to market  . The discussion focuses on the growing importance of reimbursement strategy early in product development, the operational and financial realities practices must consider before adopting new technology, and why collaboration between innovators, physicians, and practice teams is critical for success. The episode also explores how efficiency, workflow, and return on investment increasingly drive whether promising technologies ultimately make it into everyday urology practice. PRS Coding and Reimbursement HubAccess the HubBotox LCD AlertDownload the AlertFree In-Office Prostate Biopsy Calculator (Suppoted by UC-Care)Download NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and Admins Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

Is the Merit-based Incentive Payment System (MIPS) fulfilling its intended purpose, or is it just causing headaches? Dr. George Williams and Joe Reyes join host Dr. Andrew Pouw to share their expertise and experience with MIPS, including its evolultion from prior medical cost control policies and how ophthalmologists can use the IRIS Registry to meet reporting requirements.  For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts

In this episode, Jen explains what California law requires when employees use personal cell phones for work and why employers still get it wrong, especially with remote and hybrid teams. She covers where compliance fails, how liability adds up, and the practical, defensible approaches that actually work, including stipends, reimbursements, and policy language that holds up.

In this episode of Medsider Radio, we sat down with Kurt Jacobus, co-founder and CEO of restor3d.restor3d provides patient-specific orthopedic implants using 3D printing and advanced software.Kurt has over two decades of experience in medtech entrepreneurship, including successful exits to Enovis and NuVasive. Prior to his career in medical devices, Kurt was a consultant at McKinsey & Company. He holds a PhD in Mechanical Engineering and is an Adjunct Professor at Georgia Tech. In this interview, Kurt discusses how restor3d used the FDA's 520(b) pathway to generate revenue and regulatory proof simultaneously, why self-regulating beyond FDA requirements makes submissions a competitive barrier, and how to approach investor relationships and board construction with long-term thinking.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Kurt Jacobus.KEY MOMENTS FROM THE INTERVIEW(03:21) - How Kurt went from wanting to build race cars to 20 years of orthopedic entrepreneurship (06:03) - How restor3d's patient-specific implants challenge the “8 sizes fit 8 billion people” model (15:36) - Why early-stage companies should “ring the cash register” as soon as possible (17:16) - How a 520(b) pathway helped restor3d generate revenue before full FDA clearance (31:48) - How restor3d treats every FDA submission like a PhD thesis and holds itself to standards beyond what regulators ask for (35:24) - What Kurt learned from restor3d's limited market release (40:03) - How Kurt raised is last$100M+ round, and why fundraising is really a networking game (45:13) - What makes a great board, and how the wrong one can quietly derail a company

May 8, 2026In this episode, Scott, Mark, and Dr. Ray Painter discuss the growing wave of innovation in urology and why reimbursement strategy must be part of the conversation from day one. Ahead of the AUA Innovation Nexus meeting in Washington, D.C., the team explores how new technologies move from concept to clinical adoption—and the reimbursement hurdles that can slow that process down. The discussion covers coding, coverage, payer adoption, workflow planning, AI-driven practice tools, and the importance of building a realistic business plan before introducing new technology into a practice. The key takeaway: exciting technology alone is not enough—successful adoption requires clinical value, operational readiness, and a clear reimbursement strategy. PRS Coding and Reimbursement HubAccess the HubBotox LCD AlertDownload the AlertFree In-Office Prostate Biopsy Calculator (Suppoted by UC-Care)Download NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and Admins Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

In this episode of Medsider Radio, we sat down with Alfred Griffin, co-founder and CEO of LightForce.LightForce is the developer of the world's first fully customized 3D-printed bracket system directly personalized for each patient's digital treatment plan.Alfred holds a DMD and PhD in Craniofacial Biology from the Medical University of South Carolina and completed his orthodontic residency at Harvard School of Dental Medicine, where he currently serves as faculty and the Board of Fellows. An ABO-certified practicing orthodontist, he continues to see patients every month while running the company.In this interview, Alfred shares how applying existing technology to an overlooked market can unlock a larger opportunity, how adoption friction is a design problem, and why scaling a new category requires treating operations as a core product investment.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Alfred Griffin.KEY MOMENTS FROM THE INTERVIEW(02:43) - How growing up in a family of dentists shaped Alfred's path into orthodontics (07:41) - How LightForce uses digital planning and 3D printing to create fully customized braces (08:48) - Why LightForce isn't a brilliant idea, but an obvious fix for the teen braces market that aligners missed (12:19) - How LightForce is like Google Maps for teeth, eliminating detours and removing inefficiencies (17:30) - How Alfred built LightForce around his clinical strengths and hired for experience to round out the gaps (30:56) - The 3-part secret to LightForce adoption by physicians (36:42) - How Alfred approaches fundraising, matching investors to the company's stage and needs (41:51) - About LightForce's digital factories and why they're the company's core moat

Rural Health News is a weekly segment of Rural Health Today, a podcast by Hillsdale Hospital. News sources for this episode: Gary L. Roth, DO, “Fact Check: Drug Pricing Savings Are the Lifeline to Community Healthcare Services,” April 30, 2026, https://www.mha.org/newsroom/fact-check-drug-pricing-savings-are-the-lifeline-to-community-healthcare-services/, Michigan Health and Hospital Association.  American Hospital Association, “AHA urges HRSA to act as Eli Lilly threatens 340B discounts over claims data submission policy,” April 27, 2026, https://www.aha.org/news/headline/2026-04-27-aha-urges-hrsa-act-eli-lilly-threatens-340b-discounts-over-claims-data-submission-policy.  American Hospital Association, “Washington Post publishes AHA letter in response to anti-340B editorial,” April 22, 2025, https://www.aha.org/news/headline/2026-04-22-washington-post-publishes-aha-letter-response-anti-340b-editorial. Jennifer Wessel, JD, MPH, “Commercial Insurers' Payments to Hospitals Closer to Medicare Rates in Arkansas Than in Any Other State,” May 15, 2024, https://achi.net/newsroom/commercial-insurers-payments-to-hospitals-closer-to-medicare-rates-in-arkansas-than-in-any-other-state/, Arkansas Center for Health Improvement. Tess Vrbin, “Low reimbursement rates force Arkansas hospitals to scale back services,” April 21, 2026, https://arkansasadvocate.com/2026/04/21/low-reimbursement-rates-force-arkansas-hospitals-to-scale-back-services/, Arkansas Advocate. Rural Health Today is a production of Hillsdale Hospital in Hillsdale, Michigan and a member of the Health Podcast Network. Our host is JJ Hodshire, our producer is Kyrsten Newlon, and our audio engineer is Kenji Ulmer. Special thanks to our special guests for sharing their expertise on the show, and also to the Hillsdale Hospital marketing team. If you want to submit a question for us to answer on the podcast or learn more about Rural Health Today, visit ruralhealthtoday.com.

Contact us and share your opinionJoin Andy and Gandhi for the latest on GP reimbursement scheme, and collective action in General practiceSFE details: https://assets.publishing.service.gov...PCN DES contract: https://www.england.nhs.uk/publicatio...Guidance B:  https://www.england.nhs.uk/publicatio...BMA response: https://www.bma.org.uk/gpcontract?utm...Boost your triage skills with our dynamic 5-session live webinar course, tailored for primary care clinicians. Led by Dr. Gandalf and Dr. Ed Pooley, this comprehensive training covers all facets of remote patient triage—digital, on-call, and more. Gain practical knowledge, exclusive tips, and direct access to our experts through open Q&A sessions. Elevate your ability to manage primary care challenges effec Join Dr Mike as he shares how to get started and fly using EMIS to make your life easier with this clinical systembit.ly/EMIScourse

The White House wants to revamp federal contracting practices by making cost-reimbursement structures the exception, not the rule, per an executive order signed Thursday. President Donald Trump's order calls on the federal government to view fixed-price contracts with performance-based considerations as “the default and preferred method of procurement.” Department of Veterans Affairs Secretary Doug Collins told lawmakers Thursday that the VA's beleaguered electronic health record modernization efforts have turned a corner with the successful rollout of the system this month at four Michigan facilities. Collins said the April 11 deployment of the EHR at hospitals in Detroit, Ann Arbor, Battle Creek and Saginaw “has been phenomenal, even by industry standard.” The Daily Scoop Podcast is available every Monday-Friday afternoon. If you want to hear more of the latest from Washington, subscribe to The Daily Scoop Podcast  on Apple Podcasts, Soundcloud, Spotify and YouTube.

The FY 2027 SNF Proposed Rule may only be 40 pages long… but the implications for skilled nursing operators are massive.In this episode of Gravity Healthcare Hacks, Melissa Brown breaks down the biggest takeaways from the proposed rule and explains what SNF leaders should be paying attention to right now — including reimbursement changes, PDPM case mix concerns, therapy adjustments, quality reporting updates, and why CMS is signaling increased scrutiny around MDS coding and documentation.Melissa also walks through: The proposed 2.4% reimbursement increase — and why many operators feel it falls short  CMS concerns around “case mix creep” under PDPM  Proposed payment reductions to Speech, Nursing, and NTA  Why therapy components may actually increase  What operators should be advocating for before the June 1, 2026 comment deadline  How future all-payer MDS reporting could reshape quality visibility  The growing importance of Medicare Advantage quality outcomes  Why now is the time to audit your MDS processes and documentation If you operate a SNF, manage reimbursement, oversee MDS, or lead clinical operations, this is an episode you do not want to miss.Read more and access additional insights from this episode here: https://gravityhealthcareconsulting.com/gravity-healthcare-hacks-podcast/fy-2027-snf-proposed-ruleNeed help auditing your MDS processes, PDPM accuracy, or reimbursement strategy?Visit Gravity Consulting or contact Melissa Brown and the Gravity team to learn how we help SNFs improve reimbursement accuracy, operational performance, and clinical outcomes.Connect with Gravity Consulting: • Website: https://gravityconsulting.com • Contact Melissa Brown: https://gravityhealthcareconsulting.com/schedule-a-consultation • LinkedIn: https://www.linkedin.com/company/gravityhealthcareconsultingThanks for listening to Gravity Healthcare Hacks. Be sure to subscribe, leave a review, and share this episode with another healthcare leader navigating the changing SNF landscape.Support the show

The Medicaid provider says it will recoup "overpayments" retroactively.

Ready to shake up hip pain management? In this episode of BackTable MSK, we unpack how embolization is opening a new frontier for patients caught between conservative care and surgery. Interventional radiologist Dr. Kavi Krishnasamy hosts Brazilian interventionalists, Dr. Mateus Correa and Dr. Joaquim Filho, to discuss hip embolization for Greater Trochanteric Pain Syndrome (GTPS) and early hip Osteoarthritis (OA). The doctors highlight building multidisciplinary referrals, reimbursement, and the availability of embolic agents. They also address pre-procedure workup, including imaging and physical exam findings. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction 02:37 - Guest Background in MSK Embolization 08:14 - Availability of Embolics and Preferences in Brazil 10:31 - Reimbursement and Access Hurdles13:55 - Hip Etiologies Treated by Embolization 16:54 - Imaging Workup and the Role of MRI24:23 - Offering Conservative Treatment Options Prior to Embolization 26:52 - Scoring Systems and Physical Exam34:44 - Procedure Access Strategy39:16 - When to Utilize Temporary vs. Permanent Embolics46:34 - Post-Procedure and Follow-Up Guidelines58:05 - Discussion of Current Evidence --- More about this episode At the time of the procedure, Drs. Correa and Filho explain why they prefer certain vascular access points and specify arterial targets, favoring temporary embolic agents due to potential risk of Avascular Necrosis (AVN) of the femoral head. Furthermore, the doctors detail awake procedures with intraprocedural palpation and blush/pain-based endpoints, post-embolization pain flare management, follow-up schedules, and re-treatment criteria; all with consideration for current published evidence. ---Resources Dr. Mateus Correahttps://www.researchgate.net/profile/Mateus-Correa-4 Dr. Joaquim Filhohttps://www.researchgate.net/profile/Joaquim-Da-Motta-Leal-Filho --- BackTable Musculoskeletal (MSK) is the go-to podcast for musculoskeletal radiologists, interventional pain specialists, and orthopedic surgeons.Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Send us Fan MailIn Part One of this forward-looking series, Chris Comeaux unpacks the foundational challenges shaping the future of hospice and palliative care. Drawing from nearly a decade of strategic research and collaboration with healthcare leaders, he introduces a powerful framework built around eight core challenges that every organization must navigate.  From intensifying competition to shifting reimbursement models, this conversation equips leaders with a clearer lens to anticipate disruption and respond with intention.What emerges is not just a list of problems—but a strategic roadmap.  Chris explores how “hypercompetition” is reshaping referral patterns, how financial pressures demand organizational agility, and why workforce shortages require a complete rethinking of care delivery.  Throughout the episode, the emphasis remains on proactive leadership: understanding the forces at play, asking better questions, and positioning organizations to thrive—not just survive—in a rapidly evolving landscape.Ultimately, this episode serves as a call for healthcare leaders, nonprofit executives, and hospice professionals to rethink traditional models.  By embracing innovation, diversifying services, and aligning care with what patients truly want, organizations can future-proof their mission and remain deeply relevant in the years ahead.  Key TakeawaysThe future of hospice and palliative care is shaped by eight major challenges, including competition, reimbursement, workforce, and demographic shifts.  Hypercompetition is accelerating, including both direct competitors and “substitution” models that can divert referrals.  Reimbursement pressures are expected to tighten, requiring organizations to become more efficient while exploring new revenue models.  Workforce shortages are a structural reality, demanding an “outside-in” approach that aligns staffing with evolving patient needs.  Long-term success depends on organizational ambidexterity—the ability to optimize current operations while innovating new care models simultaneously.  If you're leading in hospice, healthcare, or the nonprofit space, this conversation is just the beginning.  Subscribe to the podcast, in Part Two, where we go deeper into solutions and strategies you can apply immediately. Share this episode with your leadership team, and start the conversation: Are we truly prepared for what's ahead?The Anatomy of Leadership podcast explores the art and science of leadership through candid, insightful conversations with thought leaders, innovators, and change-makers from a variety of industries. Hosted by Chris Comeaux, each episode dives into the mindsets, habits, and strategies that empower leaders to thrive in complex, fast-changing environments. With topics ranging from organizational culture and emotional intelligence to navigating disruption and inspiring teams, the show blends real-world stories with practical takeaways. The goal is simple yet ambitious: to equip leaders at every level with the tools, perspectives, and inspiration they need to lead with vision, empathy, and impact.https://www.teleioscn.org/anatomy-of-leadership

In Part One of this forward-looking series, Chris Comeaux unpacks the foundational challenges shaping the future of hospice and palliative care. Drawing from nearly a decade of strategic research and collaboration with healthcare leaders, he introduces a powerful framework built around eight core challenges that every organization must navigate.  From intensifying competition to shifting reimbursement models, this conversation equips leaders with a clearer lens to anticipate disruption and respond with intention.What emerges is not just a list of problems—but a strategic roadmap.  Chris explores how “hypercompetition” is reshaping referral patterns, how financial pressures demand organizational agility, and why workforce shortages require a complete rethinking of care delivery.  Throughout the episode, the emphasis remains on proactive leadership: understanding the forces at play, asking better questions, and positioning organizations to thrive—not just survive—in a rapidly evolving landscape.Ultimately, this episode serves as a call for healthcare leaders, nonprofit executives, and hospice professionals to rethink traditional models.  By embracing innovation, diversifying services, and aligning care with what patients truly want, organizations can future-proof their mission and remain deeply relevant in the years ahead.  Key TakeawaysThe future of hospice and palliative care is shaped by eight major challenges, including competition, reimbursement, workforce, and demographic shifts.  Hypercompetition is accelerating, including both direct competitors and “substitution” models that can divert referrals.  Reimbursement pressures are expected to tighten, requiring organizations to become more efficient while exploring new revenue models.  Workforce shortages are a structural reality, demanding an “outside-in” approach that aligns staffing with evolving patient needs.  Long-term success depends on organizational ambidexterity—the ability to optimize current operations while innovating new care models simultaneously.  If you're leading in hospice, healthcare, or the nonprofit space, this conversation is just the beginning.  Subscribe to the podcast, in Part Two, where we go deeper into solutions and strategies you can apply immediately. Share this episode with your leadership team, and start the conversation: Are we truly prepared for what's ahead?Co-Host:Cordt Kassner, PhD, Publisher of Hospice & Palliative Care Today & CEO and Founder of Hospice Analytics Host:Chris Comeaux, President / CEO of Teleios, Author of The Anatomy of LeadershipTeleios Collaborative Network   /   https://www.teleioscn.org/tcntalkspodcast

Minnesota lawmakers are still sorting through requests to reimburse cities for unplanned expenses during a surge of immigration agent activity earlier this year.And the Nobles County Board voted this morning to deny a zoning change that would've allowed data centers to be built on farmland in the southwestern Minnesota County.Those stories and more in today's evening update from MPR News. Hosted by Emily Reese. Music by Gary Meister.

Live Demo: How RCM Plus Prioritizes Denials by Predicted Reimbursement Listen to how RCM Plus uses AI to predict denial recoverability, prioritize work by expected reimbursement, and orchestrate human teams around the claims most worth pursuing. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

The 2026 Medicare Physician Fee Schedule (MPFS) final rule provides insight into how the current administration is thinking about value-based reimbursement. Adam Laughton, Shareholder, Greenberg Traurig LLP, speaks with Alex Kirkland, Senior Vice President, Coker Group, about the trajectory of value-based reimbursement and what is happening in traditional Medicare under the 2026 MPFS. They discuss issues related to alternative payment models (APMs) and conversion factors, steps that providers need to take to qualify as an APM (including investments in electronic health records and an analysis of costs versus benefits), and compliance considerations. Alex recently co-authored an article in Health Law Connections magazine about this topic. From AHLA's Physician Organizations Practice Group.Watch this episode: https://www.youtube.com/watch?v=D-ZCaG-clNIRead the Health Law Connections article: https://www.americanhealthlaw.org/content-library/connections-magazine/article/6e583147-a398-42ab-85c6-293440c564da/Review-of-the-Challenges-and-Requirements-of-BecomLearn more about AHLA's Physician Organizations Practice Group: https://www.americanhealthlaw.org/practice-groups/practice-groups/physician-organizations Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/. 

Hundreds of miles of open road can stretch between expectant mothers and the maternity care they need in rural Montana. That's where trained, non-medical professionals called “doulas” can help fill the gap. Montana was set to start reimbursing doulas through Medicaid this year, but federal cuts to the health program have put that plan on ice.

The federal government is still withholding more than $240 million in Medicaid reimbursements to Minnesota, despite approving the state's plan to address fraud concerns. Gov. Tim Walz says the funds should now be released. Thunderstorms, hail and at least one tornado scoured southern Minnesota last night.This is an MPR News Evening update, hosted by Emily Reese. Theme music is by Gary Meister.

Listen to how RCM Plus uses AI to predict denial recoverability, prioritize work by expected reimbursement, and orchestrate human teams around the claims most worth pursuing.Brought to you by www.infinx.com

Jim and Chris discuss listener emails, opening with listener PSAs on Medicare Advantage HSA reimbursement eligibility, then moving into questions on Social Security beneficiary rules and finishing their look at conduit trusts for IRAs. (7:00) A listener asks whether Social Security benefits can be passed on to a significant other. (28:00) The guys continue from last week with a listener’s multi-part question on whether a conduit trust should be structured to distribute RMDs before allowing any additional withdrawals — as a strategy for controlling how beneficiaries access inherited IRA funds. The listener also asks what else could trigger a large tax bill in that setup, and whether a conduit trust provides creditor protection. (1:15:30) George asks for the follow-up promised at the end of a recent episode — specifically, the better approach for having a trust inherit an IRA when you’re concerned about an heir mismanaging the funds. The post HSA Reimbursement, Social Security, Conduit Trusts: Q&A #2612 appeared first on The Retirement and IRA Show.